The use of vitamin C in the prevention of central venous catheter obstruction in childre

Not Applicable

• Conditions: Pathological conditions, signs and symptoms; ascorbic acid; pediatric nursing; catheter obstruction; D02.241.081.844.107; E05.325.095; H02.478.676.631

• Registration Number: RBR-4tg72t
• Lead Sponsor: Complexo do Hospital de Clínicas da Universidade Federal do Paraná

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2020-07-27
• Last Update Posted: 29 May 2023

Recruitment & Eligibility

• Status: Recruitment completed
• Sex: Not specified
• Target Recruitment: Not specified

Inclusion Criteria

Children between 28 days and 13 years 11 months and 29 days will be included in the study, using a single or double lumen central venous catheter, with the consent of the parents and/or guardians by signing the Free and Informed Consent Term - TCLE added to the Free and Informed Consent Term and that are not accompanied by serum bilirubin dosage

Exclusion Criteria

Will be excluded from the study: Carriers of nephrological diseases, clotting disorders and/or hemochromatosis; research subjects with parents under 18 years of age; research subjects whose guardians do not consent to or withdraw from the CLT; research subjects whose do not consent to or withdraw from the CLT; children with bilirubin dosage; newborns under 28 days of age; fully implanted catheter carriers; entry of medicines incompatible with ascorbic acid (etomidate, propofol, tipental, amikacin, vancomycin)

Study & Design

• Study Type: Intervention
• Study Design: Not specified